Equitec Specialists’s Mustang Bio MBIO Stock Holding History

Equitec Specialists’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1	Closed	-$4K	–	153
2019 Q2	$4K	Buy	+1	New	+$2.85K	﹤0.01%	138

Other funds holding MBIO

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Equitec Specialists's MBIO Position: Q3 2019 in Review

Equitec Specialists sold out of Mustang Bio (MBIO) in Q3 2019, closing a stake of 1 share — an estimated $4K sold.

Equitec Specialists first reported a position in MBIO in Q2 2019 and held it in 1 quarter. The position peaked at $4K in Q2 2019. 55 funds tracked by Wall St. Rank hold MBIO as of Q3 2019.

Equitec Specialists reported no remaining Mustang Bio position as of Q3 2019 after selling out during the quarter.
Equitec Specialists sold 1 Mustang Bio share in Q3 2019, an estimated $4K.
Equitec Specialists first reported a position in Mustang Bio in Q2 2019 and held it in 1 quarter.
Equitec Specialists's Mustang Bio position peaked at $4K in Q2 2019.
55 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2019.

Based on Equitec Specialists's 13F filing for Q3 2019, filed 29 Oct 2019.